Targeting TRPM3 as a potential therapeutic approach for autosomal dominant polycystic kidney disease
Abstract Cystic diseases, especially autosomal dominant polycystic kidney disease (ADPKD; incidence approx. 1/1000), are a leading cause of renal failure, caused by appearance and growth of renal cysts that can lead to renal failure in middle age. Most ADPKD cases are caused by mutations in PKD1 or...
Saved in:
Main Authors: | Hüseyin Gül, Jamie A. Davies |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-89200-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
by: Christopher M. Blanchette, et al.
Published: (2014-07-01) -
A new atypical splice mutation in PKD2 leading to autosomal dominant polycystic kidney disease in a Chinese family
by: Junlin Zhang, et al.
Published: (2024-04-01) -
Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential
by: Jingyi Yuan, et al.
Published: (2025-02-01) -
Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets
by: Xuedan Lai, et al.
Published: (2025-02-01) -
GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease
by: Wang Y, et al.
Published: (2025-02-01)